Naoko Chiba
- Microbiology top 0.2%
- Bacterial Infections and Vaccines 24
- Microbial infections and disease research 7
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 6
- Epidemiology top 2%
- Pneumonia and Respiratory Infections 40
- Respiratory viral infections research 16
- Pneumocystis jirovecii pneumonia detection and treatment 9
- Clinical Biochemistry top 5%
-
- Antimicrobial Resistance in Staphylococcus 11
-
- Streptococcal Infections and Treatments 10
Naoko Chiba
54 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 87
- Microbiology 1.0k
- Molecular Medicine 337
- Epidemiology 1.6k
- Applied Microbiology and Biotechnology 35
- Clinical Biochemistry 101
Countries citing papers authored by Naoko Chiba
This map shows the geographic impact of Naoko Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoko Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoko Chiba more than expected).
Fields of papers citing papers by Naoko Chiba
This network shows the impact of papers produced by Naoko Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoko Chiba. The network helps show where Naoko Chiba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Naoko Chiba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 0 | |
| 3 | 2014 | 1 | |
| 4 | 2013 | 1 | |
| 5 | 2013 | 17 | |
| 6 | 2013 | 7 | |
| 7 | 2012 | 16 | |
| 8 | 2012 | 161 | |
| 9 | 2012 | 30 | |
| 10 | 2011 | 1 | |
| 11 | 2011 | 9 | |
| 12 | Antibiotic susceptibility and resistance gene analysis of Haemophilus influenza in clinical tebipenem-pivoxil studies in pediatric patients using PCR method | 2009 | 3 |
| 13 | Real-time PCR detection of causative microorganisms in pediatric patients with acute otitis media in clinical phase III tebipenem-pivoxil studies | 2009 | 1 |
| 14 | Coincidence of Streptococcus pneumoniae or Haemophilus influenzae isolated simultaneously in epipharynx and middle-ear fluids in pediatric patients with acute otitis media | 2009 | 2 |
| 15 | Serotype Distribution and Antimicrobial Resistance in Invasive Pneumococcal Disease (IPD) in Japan | 2008 | 1 |
| 16 | 2007 | 21 | |
| 17 | 2006 | 87 | |
| 18 | 2006 | 2 | |
| 19 | 2005 | 47 | |
| 20 | Epidemiology of Streptococcus pneumoniae isolates from patients with meningitis between 1993 and 2002 | 2003 | 2 |
About Naoko Chiba
Naoko Chiba is a scholar working on Microbiology, Epidemiology and Molecular Medicine, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (40 papers), Bacterial Infections and Vaccines (24 papers), Respiratory viral infections research (16 papers), Antimicrobial Resistance in Staphylococcus (11 papers), Streptococcal Infections and Treatments (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Microbial infections and disease research (7 papers) and Antibiotic Resistance in Bacteria (6 papers). The work is most often cited by research in Microbiology (1.0k citations), Molecular Medicine (337 citations) and Epidemiology (1.6k citations). Naoko Chiba has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Miyuki Morozumi, Satoshi Iwata, Kimiko Ubukata, Keisuke Sunakawa, Keiko Hasegawa, Kimiko Ubukata, Reiko Kobayashi, Eiichi Nakayama, Takeaki Wajima and Somay Yamagata Murayama. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Clinical Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.